Ultrasound Device for Hair Removal
Cutera UHAIR for Hair Removal
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the Cutera UHAIR ultrasound device for hair removal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2010
CompletedFirst Posted
Study publicly available on registry
January 27, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedResults Posted
Study results publicly available
September 25, 2023
CompletedSeptember 25, 2023
September 1, 2023
1 year
January 25, 2010
August 28, 2023
September 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in Hair Count in the Treated Area
Percent hair reduction 3 months post final treatment compared to baseline in the treated areas
baseline and 3 months post final treatment (up to 28 weeks)
Study Arms (1)
Site treated with UHAIR
EXPERIMENTALThe arm, calf, and thigh will be treated
Interventions
Pulse duration 10-100 ms, fluence greater or equal to 50 J/cm2, contact tip temperature 5-30 celsus, frequency 5-20 MHz.
Eligibility Criteria
You may qualify if:
- Male or female at least 18 years of age
- Fitxpatrick skin type I-IV
- Area with unwanted hair
- Subject must be able to read, understand and sign the consent form
- Subject must adhere to the follow-up schedule and study instruction
You may not qualify if:
- Simultaneous participation in any other clinical study
- Inability or unwillingness to follow the treatment schedule
- Inability or unwillingness to sign the informed consent
- Infection in the target area
- Any disease or condition that could impair wound healing
- History of keloid formation
- History of malignant tumors in the target area
- Skin abnormalities in the target area, e.g. cuts, scrapes, wounds, scars, large moles
- History of hair removal in target area (light based or electrolysis)
- Pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cutera Inc.lead
Results Point of Contact
- Title
- Margot Doucette
- Organization
- Cutera
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2010
First Posted
January 27, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2011
Study Completion
May 1, 2011
Last Updated
September 25, 2023
Results First Posted
September 25, 2023
Record last verified: 2023-09